A study called Effisayil 2 found that spesolimab was helpful in preventing flare-ups of generalized pustular psoriasis.

Published Date: 07 Jul 2023

USA: New late-breaking data from the Effisayil 2 trial showed an 84 percent reduction in the risk for flare-ups of generalized pustular psoriasis (GPP).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

2.

Glioblastoma treatment breakthrough shows promise

3.

A computer-aided diagnostic system for improved detection of breast cancer.

4.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

5.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot